TRAX today
$47.10-$1.60 (-3.29%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minConsolidating
Daily trend turns down below $43.32
Key levels
Resistance$54.78
Resistance$47.55
Support$43.32
Support$37.31
Latest news & SEC filings
AnalystJ.P. Morgan keeps Buy rating on First Tracks Biotherapeutics with $70 target
AnalystGuggenheim keeps Buy rating on First Tracks Biotherapeutics, lifts price target
All TRAX news →Nasdaq · Healthcare
First Tracks Biotherapeutics, Inc. (TRAX)
What Is the Price Target for TRAX?
SEPT Low Target
$31.00
SEPT Mid Target
$65.00
SEPT High Target
$110.00
Analyst Consensus
$65.00
Is TRAX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TRAX.
Start Free Trial →Is TRAX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$65.00
0
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with TRAX?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Orwin John A | director | Buy | 1,300 | - | Sep 15, 2026 |
| Ware J. Anthony | director | Buy | 39,265 | $225K | Sep 2, 2026 |
| Ware J. Anthony | director | Sale | 39,265 | $1.8M | Sep 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TRAX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for TRAX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TRAX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:56 | $47.10 | 4,616 | $$217K | BUY |
| 21:00:02 | $47.10 | 2,900 | $$137K | BUY |
| 21:00:00 | $47.10 | 62,318 | $$2.9M | MIDPOINT |
| 20:36:02 | $47.78 | 9,710 | $$464K | BUY |
| 15:48:53 | $47.22 | 2,112 | $$100K | BUY |
5 dark pool trades shown · $$3.9M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for First Tracks Biotherapeutics, Inc. (TRAX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TRAX — frequently asked questions
What is TRAX stock price today?
First Tracks Biotherapeutics, Inc. (TRAX) is at $47.10, down 3.29% (-$1.60) at the Nov 13, 2026 close.
Why is TRAX stock moving today?
Latest TRAX news — Nov 13, 2026: J.P. Morgan keeps Buy rating on First Tracks Biotherapeutics with $70 target · Nov 4, 2026: Guggenheim keeps Buy rating on First Tracks Biotherapeutics, lifts price target
What is the TRAX price target?
The average analyst price target for TRAX is $65.00, ranging from $31 to $110, based on 14 analysts. Latest: Guggenheim maintains on Nov 4, 2026.
What do analysts rate TRAX?
Analyst ratings for TRAX: 0 Buy, 21 Hold, 0 Sell — consensus Hold.
Did TRAX beat earnings?
TRAX last reported on Nov 3, 2026: EPS -$0.88 vs -$0.90 expected — a beat of 2.5%.
What are TRAX support and resistance levels?
Support: $43.32, $37.31, $30.88. Resistance: $47.55, $54.78.
What are insiders doing with TRAX?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on TRAX?
Nov 13, 2026: J.P. Morgan keeps Buy rating on First Tracks Biotherapeutics with $70 target · Nov 4, 2026: Guggenheim keeps Buy rating on First Tracks Biotherapeutics, lifts price target